Active — Not RecruitingNot Applicable

Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer

Denmark1,000 participantsStarted 2017-12-01

Plain-language summary

PURPOSE: To determine the prognostic properties of a comprehensive evaluation of body composition and physical function in patients with GI-HEP cancer from point of diagnosis and throughout the treatment trajectory. GI-HEP: Patients with tumors of the upper gastrointestinal or hepatobiliary tract, specifically tumors of the esophagus, gastro-esophageal junction, stomach, primary tumors of the liver or biliary tract, as well as colorectal liver metastasis or tumors of the pancreas.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients diagnosed with histologically verified GI-HEP cancer Exclusion Criteria: * Age: \<18 * Pregnancy * Physical or mental disabilities precluding physical testing * Inability to read and understand Danish

What they're measuring

Cohort 1: Post-operative complications

Timeframe: From baseline to 30 days post surgery

Cohort 2: Medical treatment complications

Timeframe: From baseline to 1 year follow-up

Trial details

NCT IDNCT03347162

SponsorRigshospitalet, Denmark

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-12-31

View on ClinicalTrials.gov More Cancer trials